The team consist in a multidisciplinary network including chemists, physicists, biologists and clinicians, closely working together. A wide range of sensing technology is proposed, including nanomechanical sensors, electrochemical immunosensors, atomic force microscopy (AFM) and nanolithography, microfluidics, surface enhanced Raman scattering (SERS), and in-silico antibody design. A translational team made of medical doctors working in research-oriented hospitals provides a continuous feedback interaction framework for clinical inputs and validation activity.
The project involves: the Cancer Researc Hospital (CRO) in Aviano – PN, the University Hospital of Verona, the University Hospital of Udine, The university of Trieste, the University of Padova, SISSA, IOM-CNR and the Synchrotron of Trieste (Elettra).